Ixabepilone (trade name Ixempra) is a cancer medicine used to treat advanced breast cancer. It is a type of chemotherapy and is classified as a "microtubule inhibitor." Ixabepilone works by interfering with the growth of cancer cells and slowing their spread in the body. It is usually given once every three weeks, either by intravenous (IV) infusion or as an injection into a muscle. Common side effects include nausea, fatigue, anemia, and hair loss.
Ixabepilone, commercially known as Ixemplixe, is a prescription medication used for a specific type of cancer. Here's a breakdown of its key points:
Function: Microtubule Inhibitor: Ixabepilone belongs to a class of drugs called microtubule inhibitors. Microtubules are essential components of the cell skeleton that play a crucial role in cell division. Ixabepilone works by disrupting the formation and function of microtubules, hindering the process of cell division and ultimately stopping the growth and spread of cancer cells.
Applications:
- Advanced or Metastatic Breast Cancer: Ixabepilone is primarily used to treat postmenopausal women with advanced or metastatic breast cancer who have already received other forms of treatment, such as anthracycline-based chemotherapy and taxanes.
Important Considerations:
- Prescription Medication: Ixabepilone requires a doctor's prescription and close supervision due to potential side effects.
- Not a first-line treatment: It's typically used after other therapies haven't been successful.
- Combination Therapy: Ixabepilone is often combined with other chemotherapy drugs to improve treatment outcomes.
- Potential Side Effects: Like any medication, Ixabepilone can cause side effects, including:
- Fatigue
- Nausea
- Neutropenia (low white blood cell count)
- Peripheral neuropathy (tingling, numbness, or pain in the hands and feet)